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PERSPECTIVE
Cohort analysis of antenatal care and delivery outcomes  
in pregnancy: a basis for improving maternal health
A. D. Harries,1,2 A. Jahn,3,4 A. Ben-Smith,5 O. J. Gadabu,6 G. P. Douglas,7 A. Seita,8 A. Khader,8  
R. Zachariah9
Cohort analysis of tuberculosis (TB) patients regis-tered for treatment and their subsequent treat-
ment outcomes has been the cornerstone of TB moni-
toring and evaluation for nearly two decades.1 Such 
cohort analyses answer two fundamental questions: 
how many patients have been diagnosed with TB, and 
what happens to them.2 Cohort analyses at health fa-
cility level and then national level, with reports sent 
to and collated by the World Health Organization 
(WHO), have formed the basis of the WHO annual 
global reports on TB control that have been so valu-
able in informing the world about progress made and 
outstanding challenges remaining.3
This cohort monitoring system has been successfully 
adapted and used in low- and middle-income countries 
to monitor care and health service delivery for other, 
more chronic diseases, such as antiretroviral treatment 
(ART) for people living with the human immunodefi-
ciency virus/acquired immune-deficiency syndrome 
(HIV/AIDS) and the treatment of patients with diabetes 
mellitus (DM) and hypertension.4–7 We also believe that 
the routine monitoring and evaluation systems cur-
rently in use for maternal and antenatal care could be 
improved by using a cohort analysis approach.
MATERNAL AND ANTENATAL CARE
In the last two decades, progress has been made in re-
ducing global maternal mortality, but in 2010 an esti-
mated 287 000 women nevertheless died, with the ma-
jority of these deaths disproportionally affecting 
families in low- and middle-income countries.8 
Women in sub-Saharan Africa fare particularly badly, 
and maternal mortality remains high in most African 
countries, with deaths occurring as a result of obstetric 
complications such as haemorrhage, infections and 
hypertensive disorders, previous existing disease or 
disease that developed during pregnancy.9 Reducing 
maternal mortality requires much better access to 
emergency obstetric care services, but the quality and 
availability of care varies considerably from one health 
facility to another.10
At clinic level, therefore, accurate, real-time data 
on how many pregnant women are enrolling in ante-
natal care (ANC), the interventions they are receiving 
and the outcomes for mother and child provide a 
solid basis for action to monitor and improve the 
standard of care and thereby maternal health.
COHORT ANALYSES FOR MONITORING 
AND REPORTING ON ROUTINE 
ANTENATAL CARE
The cohort analysis method would be a useful ap-
proach for managing pregnant women during ANC, 
up to and including childbirth, and we believe that 
this would strengthen the current monitoring and 
evaluation systems by providing more precise infor-
mation at regular time intervals. The monthly or quar-
terly ANC cohort would be defined as all women who 
registered in the antenatal clinic in that month (e.g., 
January) or that quarter (e.g., between 1 January and 
31 March), regardless of age, duration of pregnancy, 
parity and past obstetric history. The characteristics of 
these women, included as data variables in the ANC 
treatment cards, registers and reports, could be 
adapted to the needs of any given facility, depending 
on the types of prevalent disease that affect pregnant 
women in that country. In sub-Saharan Africa, for ex-
ample, data on HIV status and ART would be import-
ant information to collect, while in other countries 
without a generalised HIV epidemic, data on DM and 
hypertension might be more important.
Some of the parameters that might be included are 
shown in Table 1. These consecutively reported 
monthly or quarterly cohorts of enrolled pregnant 
women would provide valuable information about 
new incident pregnancies, with the women stratified 
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Cohort analysis has been the cornerstone of tuberculosis 
(TB) monitoring and evaluation for nearly two decades; 
these principles have been adapted for patients with the 
human immunodeficiency virus/acquired immune-defi-
ciency syndrome on antiretroviral treatment and patients 
with diabetes mellitus and hypertension. We now make 
the case for using cohort analyses for monitoring preg-
nant women during antenatal care, up to and including 
childbirth. We believe that this approach would 
strengthen the current monitoring and evaluation sys-
tems used in antenatal care by providing more precise 
information at regular time intervals. Accurate real-time 
data on how many pregnant women are enrolled in ante-
natal care, their characteristics, the interventions they are 
receiving and the outcomes for mother and child should 
provide a solid basis for action to reduce maternal 
mortality.
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by age, time of presentation during pregnancy, co-morbid condi-
tions and relevant past obstetric histories. These data can be com-
pared between successive cohorts presenting for care, allowing 
health care providers to assess trends over time, whether access to 
health care services are improving, whether women are present-
ing earlier in their pregnancies and whether co-morbid condi-
tions and risk factors are changing.
The ANC received and the outcomes of this registration cohort 
of pregnant women need to be analysed and aggregated 6–9 
months later, depending on the earliest expected gestational age 
at enrolment in the respective setting. This is determined by the 
maximum interval between the first and last ANC visit. Data anal-
ysis should be carried out in two stages. The first stage is across all 
visits for each woman, to summarise all relevant conditions and 
interventions received in a ‘final status’. The second stage in-
volves aggregation of the final status data for all women in the re-
spective registration cohort. The resulting report will be a clear re-
cord on whether recommended ANC interventions have been 
implemented. Those that might be expected to be implemented 
in a sub-Saharan African country with endemic malaria and a 
generalised HIV epidemic are illustrated in Table 2.
Information about the number of antenatal visits, laboratory 
investigations and medical treatments is again valuable in as-
sessing whether the clinic is performing its ANC according to 
recommended practices. If performance is poor in certain areas, 
then interventions need to take place; quarterly assessments al-
low the clinic and the programme to determine whether there is 
improvement over time. Finally, the events at delivery for this 
registered cohort of pregnant women need to be recorded both 
for the mother and for the child, as illustrated in Table 3. Data 
on maternal and infant survival are important end-of-term pa-
rameters against which to assess the quality of ANC and the 
management of labour. Quantification of the different modes of 
delivery and the types of obstetric complications can help ma-
ternity health centres forecast and determine the material and 
financial resources and skilled personnel needed to ensure qual-
ity care.
The reporting of monthly or quarterly ANC cohorts should be 
aligned with the reporting of that cohort’s ANC and delivery out-
comes. One way of doing this for quarterly cohorts is shown in 
TABLE 1 Characteristics of pregnant women enrolled in a quarterly 
cohort
Characteristics of  pregnant women n (%)
Number enrolled
Age groups in years at enrolment in ANC clinic:
 10–14
 15–17
 18–24
 25–34
 35–39
 40 
Duration of current pregnancy at time of enrolment:
 First trimester (4 months or 16 weeks)
 Second trimester (4–6 months or 16–28 weeks)
 Third trimester (7–9 months or 29– 40 weeks) 
Previous obstetric history – number of pregnancies:
 1
 2–3
 4
Previous obstetric history – number of deliveries:
 1
 2–3
 4
Previous caesarean section:
 None
 1
 2
 3
Current co-morbidities and risk factors:
 Known HIV-positive
 Known diabetes mellitus
 Known hypertension
 Current cigarette smoker
ANC = antenatal care; HIV = human immunodeficiency virus.
TABLE 2 ANC interventions during pregnancy in the enrolled 
cohort
Antenatal care interventions n (%)
Number of antenatal visits per woman:
 1 visit
 2 visits
 3 visits
 4 visits
 5 visits
Tetanus toxoid doses:
 None
 1
 2
Intermittent presumptive anti-malarial treatment:
 None
 1 dose
 2 doses
Iron and folate (FeFol) tablets – received at least one supply 
Albendazole tablets – received at least one dose
Insecticide-treated bed nets – received at least one bed net
Haemoglobin first measured in ANC visit
 Haemoglobin above national agreed figure
Fasting blood glucose first measured in ANC visit
 Fasting blood glucose below the cut-off for gestational diabetes
Blood pressure first measured in ANC visit
 Blood pressure normal
Syphilis status ascertained:
 Not tested for syphilis
 Tested for syphilis
 Syphilis negative
 Syphilis positive 
HIV status ascertained during ANC visit:
 HIV status not known
 HIV status already known
 HIV test newly done in ANC
HIV status summary:
 Total HIV-negative
 Total HIV-positive
In HIV-positive women (new and previously known):
 Started or already on cotrimoxazole preventive therapy
 Started or already on ART
 ART dispensed for the baby
ANC = antenatal care; HIV = human immunodeficiency virus; ART = antiretroviral 
treatment.
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the Figure. Once the system is set up and has been running for 9 
months, the clinic needs to report every quarter on the new co-
hort of pregnant women enrolled in care, and the ANC and deliv-
ery outcomes of the cohort enrolled 9 months earlier. This is simi-
lar to how the national TB programmes report on their cohort 
data at facility and national level. However, as stated earlier, the 
outcome reports will depend on the usual gestational age at 
which mothers present, and 6 months might be better in some 
countries than 9 months.
Running paper-based record systems is possible for this type of 
cohort analysis, but a real-time, point-of-care electronic medical 
record system similar to that used for ART in Malawi,11 or for the 
management of DM and hypertension in Jordan,6,7 would be a 
better alternative. Such an electronic medical record system cur-
rently operates, for example, in Bwaila Maternity Health Centre 
in Lilongwe, Malawi, where almost 18 000 deliveries are recorded 
each year.
DISCUSSION AND CONCLUSION
With the expansion of global TB control worldwide and the scal-
ing up of ART in some of the poorest countries of the world, 
much has been learnt about how to monitor new cases coming 
on to treatment and the burden of disease and treatment out-
comes, and these have become the vital signs used to manage and 
evaluate these two treatment programmes.3,12
In Malawi, simple aggregation of prevention of mother-to-
child transmission (PMTCT) of HIV infection from ‘traditional’ 
visit-based ANC registers had resulted in inflated coverage esti-
mates due to the inability to distinguish women and visits, lead-
ing to double counting of women who were marked as ‘on ART 
drugs’ at consecutive visits. The development of a new PMTCT 
strategy in 2011, called ‘Option B+’,13 led to a cohort monitoring 
system similar to that described in this perspective article, and 
quarterly cohort reports have since become the established 
method of reporting on PMTCT and ART uptake in pregnant 
women.4
We believe that a cohort monitoring approach for ANC can be 
used in all health facility settings and that they should be ad-
justed to fit with the current epidemiology of disease in that 
country or region. For mothers who deliver outside of the health 
facility, monitoring of any kind will be a challenge. However, it is 
important that health care delivery within facilities be as good as 
possible. In these settings, there is a need for regular, structured 
and rigorous monitoring of interventions to determine whether 
the quality of care is good and whether this is making a difference 
to maternal health.
TABLE 3 Maternal and child outcomes at delivery
Outcomes at delivery n (%)
Maternal details at delivery:
 Maternal survival:
  Alive
  Dead
  Lost to follow-up
 Pregnancy term:
  Post-term (42 weeks)
  Full term (38–42 weeks)
  Near term (34–37 weeks)
  Pre-term (34 weeks)
  Abortion (spontaneous or induced)
  Not recorded or unknown
 Delivery mode:
  Spontaneous vaginal delivery
  Instrumental delivery (vacuum extraction or forceps)
  Breech
  Caesarean section 
 Site of delivery and assistance during delivery:
  Delivery at home or in health care facility (specify)
  Skilled health personnel present
  Traditional birth attendants present
 Obstetric complications:
  No complications
  Haemorrhage ante-partum
  Haemorrhage post-partum
  Obstructed labour
  Pre-eclampsia or eclampsia
  Maternal sepsis
  Ruptured uterus
  Other
Infant details at delivery:
 Babies delivered:
  Single baby
  Twin babies
  Three or more babies
 Infant survival:
  Live birth
  Fresh still birth
  Macerated still birth 
 Birth weight:
  Low (2500 g)
  Normal (2500–4500 g)
  High (4500 g)
  Not recorded
FIGURE Dates of reporting of A) the antenatal quarterly cohort at 
registration and B) the antenatal quarterly cohort at time of delivery 
(9 months later). ANC = antenatal care; Q = quarter.
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Une analyse de cohorte a été la pierre angulaire du suivi et évaluation 
de la tuberculose pendant près de deux décennies ; ces principes ont 
été adaptés aux patients atteints de virus de l’immunodéficience 
humaine/syndrome de l’immunodéficience acquise sous traitement 
antiretroviral, ainsi qu’aux patients ayant un diabète et une 
hypertension. Nous recommandons maintenant l’utilisation d’analyse 
de cohorte pour le suivi des femmes enceintes en consultation 
prénatale et jusqu’à l’accouchement inclus. Nous pensons que cette 
approche renforcerait le système actuel de suivi et évaluation utilisé 
en consultation prénatale en fournissant des informations plus 
précises à intervalles réguliers. Des données exactes en temps réel sur 
le nombre de femmes enceintes enrôlées en consultation prénatale, 
leurs caractéristiques, l’intervention mise en place et les résultats vis-
à-vis de la mère et de l’enfant, devraient fournir une solide base 
d’action visant à diminuer la mortalité maternelle.  
El análisis de cohortes ha constituido la piedra angular del seguimiento 
y de la evaluación de la tuberculosis durante cerca de dos decenios; 
estos principios se adaptaron a los pacientes coinfectados por el virus 
de la inmunodeficiencia humana y la síndrome de la inmunodeficiencia 
adquirida que reciben tratamiento antirretrovírico y a los pacientes 
con diabetes e hipertensión. En el presente artículo se defiende la 
oportunidad de utilizar los análisis de cohortes en el seguimiento de 
las embarazadas durante el cuidado prenatal, hasta incluir el 
nacimiento. Se propone que esta estrategia reforzaría los sistemas de 
seguimiento y evaluación que se practican actualmente en la atención 
prenatal, pues aportaría información más precisa y a intervalos 
regulares. Obtener los datos exactos y en tiempo real sobre la forma 
como las embarazadas se inscriben a la atención prenatal, sus 
características, las principales intervenciones que reciben y los 
desenlaces de la madre y el niño aportaría fundamentos sólidos a las 
actividades encaminadas a disminuir la mortalidad materna.
